The prognostic effects of somatic mutations in ER-positive breast cancer
DNA damage repair defects as a new class of endocrine treatment resistance driver
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
Activating HER2 mutations in HER2 gene amplification negative breast cancer
Connecting genomic alterations to cancer biology with proteomics
ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer
Genome remodelling in a basal-like breast cancer metastasis and xenograft
New concepts in breast cancer genomics and genetics. Breast cancer research
Whole-genome analysis informs breast cancer response to aromatase inhibition
The genomic landscape of breast cancer as a therapeutic roadmap
For more publications visit: